| LBCTR2019090238 | SHP647-302 | A study of the Efficacy and Safety of SHP647 as Induction Therapy in Subjects with Moderate to Severe Ulcerative Colitis | A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects with Moderate to Severe Ulcerative Colitis | Interventional | Other | 27/05/2019 |
| LBCTR2019090248 | SHP647-306 | A study of the Efficacy and Safety of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn’s Disease (CARMEN CD 306) | A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn’s Disease (CARMEN CD 306) | Interventional | Other | 26/06/2019 |
| LBCTR2020011375 | CICL670E2419 | THETIS- Efficacy and Safety Study of Deferasirox in Patients With Non-transfusion Dependent Thalassemia | An Open Label, Multi-center, Efficacy and Safety Study of Deferasirox in Iron Overloaded Patients With Non-transfusion Dependent Thalassemia | Interventional | Complete | 01/01/2020 |
| LBCTR2020012391 | LBCTR2020012391 | Effect of cycle ergometer training on balance and cognition in moderate to severely demented elderly, a Randomized Clinical Trial | Effect of cycle ergometer training on balance and cognition in moderate to severely demented elderly, a Randomized Clinical Trial | Interventional | Complete | 29/01/2020 |
| LBCTR2020023398 | LAUMCRH.RH2.4/Dec/2019 | The Efficacy of Octenidine in Sinusitis compared to standard of care | The Efficacy of Octenidine in Sinusitis compared to standard of care | Interventional | Pending | 18/02/2020 |
| LBCTR2020093402 | IMR-BTL-201 | A Phase 2 Study to Evaluate the Safety and Tolerability of IMR-687 in Subjects with Beta Thalassemia | A Phase 2 Study to Evaluate the Safety and Tolerability of IMR-687 in Subjects with Beta Thalassemia | Interventional | Pending | 24/02/2020 |
| LBCTR2020083421 | IMR-SCD-301 | A Phase 2b Study to Evaluate the Safety and Efficacy of IMR-687 in Subjects with Sickle Cell Disease | A Phase 2b Study to Evaluate the Safety and Efficacy of IMR-687 in Subjects with Sickle Cell Disease | Interventional | Pending | 26/08/2020 |
| LBCTR2020063422 | MRX-502 | A Placebo-controlled study of Maralixibat in Subjects with Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC) | MRX-502: Randomized Double-blind Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Maralixibat in the Treatment of Subjects with Progressive Familial Intrahepatic Cholestasis (PFIC) – MARCH-PFIC | Interventional | Recruiting | 03/03/2020 |
| LBCTR2020033424 | LAU.SOP.LK2.11/Jul/2017 | Impact of pharmacist educational interventions on patients with anticoagulants | Impact of pharmacist-conducted anticoagulation patient education and telephone follow-up on transitions of care: A randomized controlled trial | Interventional | Complete | 10/03/2020 |
| LBCTR2020043428 | APD334-303 | An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis | An Open-Label Extension Study of Etrasimod in Subjects With Moderately to Severely Active Ulcerative Colitis | Interventional | Pending | 01/12/2020 |